<DOC>
	<DOCNO>NCT02256930</DOCNO>
	<brief_summary>This single center , randomize , control , within subject comparison , multiple dose study determine sensitization potential M518101 normal skin occlusive patch condition .</brief_summary>
	<brief_title>Skin Safety Study Evaluate Sensitizing Potential Healthy Volunteers</brief_title>
	<detailed_description>During Induction Phase study , study drug control apply 9 time 21 day infrascapular area back occlusive patch condition . Following induction , subject 10 14-day Rest phase , enter challenge Phase , consist one 48-hour patch application ( occlusive ) na√Øve site opposite side back .</detailed_description>
	<criteria>Health male female subject age 18 year old Signed date Informed Consent Form obtain prior study related activity Subjects free systemic dermatologic disorder For female , female non childbearing potential agree use highly effective method birth control study negative urine pregnancy test Subjects must able communicate investigator understand comply requirement study visit schedule Have visible skin disease application site interfere evaluation test site reaction Have damage skin around test site Have history sensitivity adhesive tape Have know sensitivity constituent present material evaluate Have history , currently treat skin cancer Have use study drug and/or participate clinical study within 60 day prior randomization To engage type strenuous exercise Are pregnant , breastfeeding , childbearing potential wish become pregnant study Are deem ineligible investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>